{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T02:55:12Z","timestamp":1791600912199,"version":"4.3.4"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T00:00:00Z","timestamp":1748217600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T00:00:00Z","timestamp":1748217600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"DOI":"10.1186\/s12951-025-03445-4","type":"journal-article","created":{"date-parts":[[2025,5,25]],"date-time":"2025-05-25T21:44:45Z","timestamp":1748209485000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["A lyophilizable LNP vaccine enables STING-reinforced postoperational adjuvant immunotherapy"],"prefix":"10.1186","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-9634-6605","authenticated-orcid":false,"given":"Yi","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-2267-2600","authenticated-orcid":false,"given":"Jiaxin","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6361-7479","authenticated-orcid":false,"given":"Jialong","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenxia","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jialin","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8560-7714","authenticated-orcid":false,"given":"Muhammad Waqqas","family":"Hasan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5606-0278","authenticated-orcid":false,"given":"Fei","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0779-9519","authenticated-orcid":false,"given":"You","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengji","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9413-0978","authenticated-orcid":false,"given":"Wei","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9512-9664","authenticated-orcid":false,"given":"Wenjie","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,26]]},"reference":[{"issue":"1","key":"3445_CR1","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s12943-023-01740-y","volume":"22","author":"A Lahiri","year":"2023","unstructured":"Lahiri A, Maji A, Potdar PD, Singh N, Parikh P, Bisht B, Mukherjee A, Paul MK. Lung cancer immunotherapy: progress, pitfalls, and promises. Mol Cancer. 2023;22(1):40.","journal-title":"Mol Cancer"},{"issue":"11","key":"3445_CR2","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1038\/s41577-020-0306-5","volume":"20","author":"AD Waldman","year":"2020","unstructured":"Waldman AD, Fritz JM, Lenardo MJ. A guide to cancer immunotherapy: from T cell basic science to clinical practice. Nat Rev Immunol. 2020;20(11):651\u201368.","journal-title":"Nat Rev Immunol"},{"issue":"12","key":"3445_CR3","first-page":"785","volume":"21","author":"K DePeaux","year":"2021","unstructured":"DePeaux K, Delgoffe GM. Metabolic barriers to cancer immunotherapy. Nat Rev Immunolo. 2021;21(12):785\u201397.","journal-title":"Immunology"},{"issue":"7","key":"3445_CR4","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/j.it.2022.04.010","volume":"43","author":"J Zhang","year":"2022","unstructured":"Zhang J, Huang D, Saw PE, Song E. Turning cold tumors hot: from molecular mechanisms to clinical applications. Trends Immunol. 2022;43(7):523\u201345.","journal-title":"Trends Immunol"},{"issue":"7","key":"3445_CR5","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1038\/s41573-021-00189-2","volume":"20","author":"AJ Hou","year":"2021","unstructured":"Hou AJ, Chen LC, Chen YY. Navigating CAR-T cells through the solid-tumour microenvironment. Nat Rev Drug Discovery. 2021;20(7):531\u201350.","journal-title":"Nature Reviews Drug Discovery"},{"issue":"4","key":"3445_CR6","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/nri2274","volume":"8","author":"RA Seder","year":"2008","unstructured":"Seder RA, Darrah PA, Roederer M. T-cell quality in memory and protection: implications for vaccine design. Nat Rev Immunol. 2008;8(4):247\u201358.","journal-title":"Nat Rev Immunol"},{"key":"3445_CR7","doi-asserted-by":"crossref","unstructured":"Li S, Simoni Y, Zhuang S, Gabel A, Ma S, Chee J, et al. Characterization of neoantigen-specific T cells in cancer resistant to immune checkpoint therapies. Proc Natl Acad Sci. 2021;118(30).","DOI":"10.1073\/pnas.2025570118"},{"key":"3445_CR8","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.canlet.2019.11.039","volume":"471","author":"R Wang","year":"2020","unstructured":"Wang R, Pan W, Jin L, Huang W, Li Y, Wu D, Gao C, Ma D, Liao S. Human papillomavirus vaccine against cervical cancer: opportunity and challenge. Cancer Lett. 2020;471:88\u2013102.","journal-title":"Cancer Lett"},{"key":"3445_CR9","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.1007\/s10529-021-03166-2","volume":"43","author":"T Mousavi","year":"2021","unstructured":"Mousavi T, Valadan R, Rafiei A, Abbasi A, Haghshenas MR. A novel Recombinant protein vaccine containing the different E7 proteins of the HPV16, 18, 6, 11 E7 linked to the HIV-1 Tat (47\u201357) improve cytotoxic immune responses. Biotechnol Lett. 2021;43:1933\u201344.","journal-title":"Biotechnol Lett"},{"issue":"1\u20132","key":"3445_CR10","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.virol.2013.04.013","volume":"445","author":"A Roman","year":"2013","unstructured":"Roman A, Munger K. The papillomavirus E7 proteins. Virology. 2013;445(1\u20132):138\u201368.","journal-title":"Virology"},{"issue":"6","key":"3445_CR11","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1038\/s41568-021-00346-0","volume":"21","author":"M Saxena","year":"2021","unstructured":"Saxena M, van der Burg SH, Melief CJ, Bhardwaj N. Therapeutic cancer vaccines. Nat Rev Cancer. 2021;21(6):360\u201378.","journal-title":"Nat Rev Cancer"},{"issue":"8","key":"3445_CR12","doi-asserted-by":"publisher","first-page":"2001934","DOI":"10.1002\/adhm.202001934","volume":"10","author":"Y Shi","year":"2021","unstructured":"Xiong D, Zhang L, Sun Z-J: Targeting the epigenome to reinvigorate T cells for cancer immunotherapy. Mil Med Res. 2023;10:59.","journal-title":"Adv Healthc Mater"},{"issue":"6","key":"3445_CR13","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1038\/s41568-023-00562-w","volume":"23","author":"B Ruf","year":"2023","unstructured":"Ruf B, Greten TF, Korangy F. Innate lymphoid cells and innate-like T cells in cancer\u2014at the crossroads of innate and adaptive immunity. Nat Rev Cancer. 2023;23(6):351\u201371.","journal-title":"Nat Rev Cancer"},{"issue":"7","key":"3445_CR14","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1002\/mc.23212","volume":"59","author":"MM Hoffmann","year":"2020","unstructured":"Sanz-Ortega L, Portilla Y, P\u00e9rez-Yag\u00fce S, Barber DF: magnetic targeting of adoptively transferred tumour-specific nanoparticle-loaded CD8(+) T cells does not improve their tumour infiltration in a mouse model of cancer but promotes the retention of these cells in tumour-draining lymph nodes. J Nanobiotechnol. 2019;17:87.","journal-title":"Mol Carcinog"},{"issue":"1","key":"3445_CR15","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/s41423-020-00568-6","volume":"18","author":"AK Horst","year":"2021","unstructured":"Horst AK, Kumashie KG, Neumann K, Diehl L, Tiegs G. Antigen presentation, autoantibody production, and therapeutic targets in autoimmune liver disease. Cell Mol Immunol. 2021;18(1):92\u2013111.","journal-title":"Cell Mol Immunol"},{"issue":"9","key":"3445_CR16","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1038\/s41580-020-0244-x","volume":"21","author":"K-P Hopfner","year":"2020","unstructured":"Hopfner K-P, Hornung V. Molecular mechanisms and cellular functions of cGAS\u2013STING signalling. Nat Rev Mol Cell Biol. 2020;21(9):501\u201321.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"1","key":"3445_CR17","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.immuni.2020.05.013","volume":"53","author":"X Zhang","year":"2020","unstructured":"Zhang X, Bai X-c, Chen ZJ. Structures and mechanisms in the cGAS-STING innate immunity pathway. Immunity. 2020;53(1):43\u201353.","journal-title":"Immunity"},{"key":"3445_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13045-020-00916-z","volume":"13","author":"M Jiang","year":"2020","unstructured":"Jiang M, Chen P, Wang L, Li W, Chen B, Liu Y, Wang H, Zhao S, Ye L, He Y. cGAS-STING, an important pathway in cancer immunotherapy. J Hematol Oncol. 2020;13:1\u201311.","journal-title":"J Hematol Oncol"},{"issue":"20","key":"3445_CR19","doi-asserted-by":"publisher","first-page":"3582","DOI":"10.1016\/j.molcel.2023.09.022","volume":"83","author":"KA Cimprich","year":"2023","unstructured":"Cimprich KA, Li G-M, Demaria S, Gekara NO, Zha S, Chen Q. The crosstalk between DNA repair and immune responses. Mol Cell. 2023;83(20):3582\u20137.","journal-title":"Mol Cell"},{"issue":"79","key":"3445_CR20","doi-asserted-by":"publisher","first-page":"eabn6612","DOI":"10.1126\/sciimmunol.abn6612","volume":"8","author":"B Jneid","year":"2023","unstructured":"Jneid B, Bochnakian A, Hoffmann C, Delisle F, Djacoto E, Sirven P, Denizeau J, Sedlik C, Gerber-Ferder Y, Fiore F. Selective STING stimulation in dendritic cells primes antitumor T cell responses. Sci Immunol. 2023;8(79):eabn6612.","journal-title":"Sci Immunol"},{"key":"3445_CR21","doi-asserted-by":"crossref","unstructured":"Li W, Lu L, Lu J, Wang X, Yang C, Jin J, et al. cGAS-STING-mediated DNA sensing maintains CD8 (+) T cell stemness and promotes antitumor T cell therapy. Sci Transl Med. 2022;12(549).","DOI":"10.1126\/scitranslmed.aay9013"},{"issue":"6506","key":"3445_CR22","doi-asserted-by":"publisher","first-page":"eaba6098","DOI":"10.1126\/science.aba6098","volume":"369","author":"B-S Pan","year":"2020","unstructured":"Pan B-S, Perera SA, Piesvaux JA, Presland JP, Schroeder GK, Cumming JN, Trotter BW, Altman MD, Buevich AV, Cash B. An orally available non-nucleotide STING agonist with antitumor activity. Science. 2020;369(6506):eaba6098.","journal-title":"Science"},{"key":"3445_CR23","doi-asserted-by":"publisher","first-page":"216765","DOI":"10.1016\/j.canlet.2024.216765","volume":"588","author":"Y Yang","year":"2024","unstructured":"Yang Y, Qi J, Hu J, Zhou Y, Zheng J, Deng W, Inam M, Guo J, Xie Y, Li Y, Xu C, Deng W, Chen W. Lovastatin\/SN38 co-loaded liposomes amplified ICB therapeutic effect via remodeling the immunologically-cold colon tumor and synergized stimulation of cGAS-STING pathway. Cancer Lett. 2024;588:216765.","journal-title":"Cancer Lett"},{"issue":"19","key":"3445_CR24","doi-asserted-by":"publisher","first-page":"2205409","DOI":"10.1002\/adma.202205409","volume":"35","author":"K Zhang","year":"2023","unstructured":"Zhang K, Qi C, Cai K. Manganese-based tumor immunotherapy. Adv Mater. 2023;35(19):2205409.","journal-title":"Adv Mater"},{"key":"3445_CR25","doi-asserted-by":"crossref","unstructured":"Nicolai CJ, Wolf N, Chang IC, Kirn G, Marcus A, Ndubaku CO, et al. NK cells mediate clearance of CD8 (+) T cell-resistant tumors in response to STING agonists. Sci Immunol. 2020;5(45):eaaz2738.","DOI":"10.1126\/sciimmunol.aaz2738"},{"issue":"1","key":"3445_CR26","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1021\/mp060098+","volume":"4","author":"A Br\u00e5ve","year":"2007","unstructured":"Br\u00e5ve A, Ljungberg K, Wahren B, Liu MA. Vaccine delivery methods using viral vectors. Mol Pharm. 2007;4(1):18\u201332.","journal-title":"Mol Pharm"},{"key":"3445_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1476-4598-10-3","volume":"10","author":"A Bolhassani","year":"2011","unstructured":"Bolhassani A, Safaiyan S, Rafati S. Improvement of different vaccine delivery systems for cancer therapy. Mol Cancer. 2011;10:1\u201320.","journal-title":"Mol Cancer"},{"issue":"21","key":"3445_CR28","doi-asserted-by":"publisher","first-page":"2202168","DOI":"10.1002\/adma.202202168","volume":"34","author":"J Meng","year":"2022","unstructured":"Meng J, Zhang P, Chen Q, Wang Z, Gu Y, Ma J, Li W, Yang C, Qiao Y, Hou Y. Two-Pronged intracellular Co\u2010Delivery of antigen and adjuvant for synergistic Cancer immunotherapy. Adv Mater. 2022;34(21):2202168.","journal-title":"Adv Mater"},{"key":"3445_CR29","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.jconrel.2020.06.021","volume":"326","author":"Y Hou","year":"2020","unstructured":"Hou Y, Wang Y, Tang Y, Zhou Z, Tan L, Gong T, Zhang L, Sun X. Co-delivery of antigen and dual adjuvants by aluminum hydroxide nanoparticles for enhanced immune responses. J Controlled Release. 2020;326:120\u201330.","journal-title":"J Controlled Release"},{"issue":"2","key":"3445_CR30","doi-asserted-by":"publisher","first-page":"2100109","DOI":"10.1002\/anbr.202100109","volume":"2","author":"L Xu","year":"2022","unstructured":"Guo J, Gu M, Chen Y, Xiong T, Zhang Y, Chen S, et al. Nucleic acid delivery by lipid nanoparticles for organ targeting. Chin Chem Lett. 2025: 110849.","journal-title":"Adv NanoBiomed Res"},{"key":"3445_CR31","doi-asserted-by":"publisher","first-page":"114416","DOI":"10.1016\/j.addr.2022.114416","volume":"188","author":"CH Albertsen","year":"2022","unstructured":"Albertsen CH, Kulkarni JA, Witzigmann D, Lind M, Petersson K, Simonsen JB. The role of lipid components in lipid nanoparticles for vaccines and gene therapy. Adv Drug Deliv Rev. 2022;188:114416.","journal-title":"Adv Drug Deliv Rev"},{"issue":"5","key":"3445_CR32","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1038\/s41423-021-00669-w","volume":"18","author":"R Zhang","year":"2021","unstructured":"Zhang R, Wang C, Guan Y, Wei X, Sha M, Yi M, Jing M, Lv M, Guo W, Xu J. Manganese salts function as potent adjuvants. Cell Mol Immunol. 2021;18(5):1222\u201334.","journal-title":"Cell Mol Immunol"},{"issue":"11","key":"3445_CR33","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1038\/s41422-020-00395-4","volume":"30","author":"M Lv","year":"2020","unstructured":"Lv M, Chen M, Zhang R, Zhang W, Wang C, Zhang Y, Wei X, Guan Y, Liu J, Feng K. Manganese is critical for antitumor immune responses via cGAS-STING and improves the efficacy of clinical immunotherapy. Cell Res. 2020;30(11):966\u201379.","journal-title":"Cell Res"},{"issue":"16","key":"3445_CR34","doi-asserted-by":"publisher","first-page":"15905","DOI":"10.1021\/acsnano.3c03962","volume":"17","author":"S-J Zheng","year":"2023","unstructured":"Zheng S-J, Yang M, Luo J-Q, Liu R, Song J, Chen Y. Du, Manganese-Based immunostimulatory Metal\u2013Organic framework activates the cGAS-STING pathway for Cancer metalloimmunotherapy. ACS Nano. 2023;17(16):15905\u201317.","journal-title":"ACS Nano"},{"key":"3445_CR35","doi-asserted-by":"publisher","first-page":"112178","DOI":"10.1016\/j.matdes.2023.112178","volume":"233","author":"C Peng","year":"2023","unstructured":"Peng C, Zhao M, Wang X, Yan M, Han Y, Chen D, Hu H. Manganese ion gradient liposomes modified by disulfide bond enhance cellular uptake and tumor immunity. Mater Design. 2023;233:112178.","journal-title":"Mater Design"},{"issue":"1","key":"3445_CR36","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s12645-023-00182-x","volume":"14","author":"RG Thomas","year":"2023","unstructured":"Thomas RG, Kim S, Nagareddy R, Vijayan V, Pullickal AM, Yoon MS, Park IK, Jeong YY. Lipo-MGN nanoparticle hypoxia attenuation-mediated single-dose radiotherapy-and pH\/ROS-responsive T1 contrast magnetic resonance imaging in hepatocellular carcinoma. Cancer Nanotechnol. 2023;14(1):53.","journal-title":"Cancer Nanotechnol"},{"issue":"44","key":"3445_CR37","doi-asserted-by":"publisher","first-page":"30701","DOI":"10.1021\/acsnano.4c09902","volume":"18","author":"Z Luo","year":"2024","unstructured":"Luo Z, Lin Y, Meng Y, Li M, Ren H, Shi H, Cheng Q, Wei T. Spleen-Targeted mRNA vaccine doped with manganese adjuvant for robust anticancer immunity in vivo. ACS Nano. 2024;18(44):30701\u201315.","journal-title":"ACS Nano"},{"issue":"9","key":"3445_CR38","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1038\/79470","volume":"18","author":"MA Chattergoon","year":"2000","unstructured":"Chattergoon MA, Kim JJ, Yang J-S, Robinson TM, Lee DJ, Dentchev T, Wilson DM, Ayyavoo V, Weiner DB. Targeted antigen delivery to antigen\u2013presenting cells including dendritic cells by engineered Fas-mediated apoptosis. Nat Biotechnol. 2000;18(9):974\u20139.","journal-title":"Nat Biotechnol"},{"issue":"2","key":"3445_CR39","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1002\/cbic.200700310","volume":"9","author":"EW Adams","year":"2008","unstructured":"Adams EW, Ratner DM, Seeberger PH, Hacohen N. Carbohydrate-mediated targeting of antigen to dendritic cells leads to enhanced presentation of antigen to T cells. ChemBioChem. 2008;9(2):294\u2013303.","journal-title":"ChemBioChem"},{"issue":"9","key":"3445_CR40","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.3390\/vaccines9091033","volume":"9","author":"MN Uddin","year":"2021","unstructured":"Uddin MN, Roni MA. Challenges of storage and stability of mRNA-based COVID-19 vaccines. Vaccines. 2021;9(9):1033.","journal-title":"Vaccines"},{"issue":"5","key":"3445_CR41","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1016\/j.ymthe.2022.02.001","volume":"30","author":"H Muramatsu","year":"2022","unstructured":"Muramatsu H, Lam K, Bajusz C, Laczk\u00f3 D, Karik\u00f3 K, Schreiner P, Martin A, Lutwyche P, Heyes J, Pardi N. Lyophilization provides long-term stability for a lipid nanoparticle-formulated, nucleoside-modified mRNA vaccine. Mol Ther. 2022;30(5):1941\u201351.","journal-title":"Mol Ther"},{"issue":"1","key":"3445_CR42","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/S0168-3659(98)00130-8","volume":"58","author":"EC van Winden","year":"1999","unstructured":"van Winden EC, Crommelin DJ. Short term stability of freeze-dried, lyoprotected liposomes. J Controlled Release. 1999;58(1):69\u201386.","journal-title":"J Controlled Release"},{"issue":"9","key":"3445_CR43","doi-asserted-by":"publisher","first-page":"2417","DOI":"10.1002\/eji.1830270941","volume":"27","author":"AJ Engering","year":"1997","unstructured":"Li Y, Zhu R, Guo Y, Wang Y, Ma R, Ma K, et al. Sequential-gated transformable nanoprodrug potentiates antitumor immunity through TME modulation and STING activation. Chin Chem Lett. 2024:110704.","journal-title":"Eur J Immunol"},{"issue":"2","key":"3445_CR44","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.it.2004.12.001","volume":"26","author":"PR Taylor","year":"2005","unstructured":"Taylor PR, Gordon S, Martinez-Pomares L. The mannose receptor: linking homeostasis and immunity through sugar recognition. Trends Immunol. 2005;26(2):104\u201310.","journal-title":"Trends Immunol"},{"key":"3445_CR45","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.bioactmat.2023.11.017","volume":"33","author":"X Deng","year":"2024","unstructured":"Deng X, Liu T, Zhu Y, Chen J, Song Z, Shi Z, Chen H. Ca & Mn dual-ion hybrid nanostimulator boosting anti-tumor immunity via ferroptosis and innate immunity awakening. Bioactive Mater. 2024;33:483\u201396.","journal-title":"Bioactive Mater"},{"issue":"3","key":"3445_CR46","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1038\/s41423-020-00611-6","volume":"18","author":"Y Wu","year":"2021","unstructured":"Wu Y, Tang CA, Mealer C, Bastian D, Hanief Sofi M, Tian L, Schutt S, Choi HJ, Ticer T, Zhang M, Sui X, Huang L, Mellor AL, Hu CA, Yu XZ. STING negatively regulates allogeneic T-cell responses by constraining antigen-presenting cell function. Cell Mol Immunol. 2021;18(3):632\u201343.","journal-title":"Cell Mol Immunol"},{"issue":"1","key":"3445_CR47","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/s41565-018-0319-4","volume":"14","author":"Q Chen","year":"2019","unstructured":"Chen Q, Wang C, Zhang X, Chen G, Hu Q, Li H, Wang J, Wen D, Zhang Y, Lu Y, Yang G, Jiang C, Wang J, Dotti G, Gu Z. In situ sprayed bioresponsive immunotherapeutic gel for post-surgical cancer treatment. Nat Nanotechnol. 2019;14(1):89\u201397.","journal-title":"Nat Nanotechnol"},{"issue":"12","key":"3445_CR48","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1158\/2159-8290.CD-16-0577","volume":"6","author":"J Liu","year":"2016","unstructured":"Liu J, Blake SJ, Yong MC, Harjunp\u00e4\u00e4 H, Ngiow SF, Takeda K, Young A, O\u2019Donnell JS, Allen S, Smyth MJ, Teng MW. Improved efficacy of neoadjuvant compared to adjuvant immunotherapy to eradicate metastatic disease. Cancer Discov. 2016;6(12):1382\u201399.","journal-title":"Cancer Discov"},{"issue":"39","key":"3445_CR49","first-page":"e2103497","volume":"33","author":"Y Wang","year":"2021","unstructured":"Wang Y, Yu J, Luo Z, Shi Q, Liu G, Wu F, et al. Engineering endogenous tumor-Associated Macrophage-Targeted biomimetic Nano-RBC to reprogram tumor immunosuppressive microenvironment for enhanced Chemo-Immunotherapy. Adv Mat. 2021;33(39):e2103497.","journal-title":"Fla)"},{"issue":"8004","key":"3445_CR50","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1038\/s41586-024-07098-5","volume":"627","author":"AG York","year":"2024","unstructured":"York AG, Skadow MH, Oh J, Qu R, Zhou QD, Hsieh WY, Mowel WK, Brewer JR, Kaffe E, Williams KJ, Kluger Y, Smale ST, Crawford JM, Bensinger SJ, Flavell RA. IL-10 constrains sphingolipid metabolism to limit inflammation. Nature. 2024;627(8004):628\u201335.","journal-title":"Nature"},{"key":"3445_CR51","doi-asserted-by":"crossref","unstructured":"Chelvanambi M, Fecek RJ, Taylor JL, Storkus WJ. STING agonist-based treatment promotes vascular normalization and tertiary lymphoid structure formation in the therapeutic melanoma microenvironment. J Immunother Cancer. 2021;9(2):e001906.","DOI":"10.1136\/jitc-2020-001906"},{"issue":"6","key":"3445_CR52","doi-asserted-by":"publisher","first-page":"5977","DOI":"10.1021\/acs.chemrev.1c00750","volume":"122","author":"KM Garland","year":"2022","unstructured":"Garland KM, Sheehy TL, Wilson JT. Chemical and biomolecular strategies for STING pathway activation in Cancer immunotherapy. Chem Rev. 2022;122(6):5977\u20136039.","journal-title":"Chem Rev"},{"issue":"4","key":"3445_CR53","doi-asserted-by":"publisher","first-page":"3927","DOI":"10.1021\/acsnano.9b06111","volume":"14","author":"L Hou","year":"2020","unstructured":"Hou L, Tian C, Yan Y, Zhang L, Zhang H, Zhang Z. Manganese-based nanoactivator optimizes cancer immunotherapy via enhancing innate immunity. ACS Nano. 2020;14(4):3927\u201340.","journal-title":"ACS Nano"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-025-03445-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-025-03445-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-025-03445-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,25]],"date-time":"2025-05-25T23:18:25Z","timestamp":1748215105000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnanobiotechnology.biomedcentral.com\/articles\/10.1186\/s12951-025-03445-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,26]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3445"],"URL":"https:\/\/doi.org\/10.1186\/s12951-025-03445-4","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-5839387\/v1","asserted-by":"object"}]},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,26]]},"assertion":[{"value":"16 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All the animal studies have been approved by the Guangzhou Medical University IACUC under the ethics approval GY-2022-188.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors agree with the content of the manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"379"}}